Reports for APOTEX INC

Formerly known as AA PHARMA INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

220 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

3124 (93%)

3354

Discontinuation Reports

To be discontinued:

26 (7%)

Discontinued:

343 (93%)

Reversed:

0 (0%)

369

145 (4%)

73 (30%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-SIMVASTATIN 40MG TABLET Resolved 2020-03-04 2020-04-09 107714
APO-SIMVASTATIN 80MG TABLET Resolved 2020-01-15 2020-04-09 103391
APO-SIMVASTATIN 20MG TABLET Resolved 2021-07-23 2022-03-01 142985
APO-SIMVASTATIN 80MG TABLET Resolved 2020-05-08 2020-09-01 114321
APO-SITAGLIPTIN MALATE 25MG TABLET Resolved 2024-04-12 2024-05-31 224977
APO-SITAGLIPTIN MALATE 25MG TABLET Resolved 2024-08-29 2024-10-04 236246
APO-SITAGLIPTIN MALATE 25MG TABLET Resolved 2024-05-10 2024-05-31 227717
APO-SITAGLIPTIN MALATE 100MG TABLET Resolved 2024-04-26 2024-06-21 226345
APO-SITAGLIPTIN MALATE 100MG TABLET Resolved 2023-03-30 2023-04-14 188411
APO-SITAGLIPTIN MALATE 100MG TABLET Resolved 2024-05-03 2024-06-21 227016
APO-SITAGLIPTIN MALATE 25MG TABLET Resolved 2023-02-09 2023-04-06 184112
APO-SITAGLIPTIN MALATE 50MG TABLET Resolved 2024-04-12 2024-05-31 224996
APO-SITAGLIPTIN MALATE 50MG TABLET Resolved 2023-03-30 2023-05-19 188415
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 500MG 50MG TABLET Resolved 2023-01-06 2023-07-27 180124
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 850MG 50MG TABLET Resolved 2023-03-02 2023-10-06 185951
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 500MG 50MG TABLET Resolved 2023-03-02 2023-07-27 185948
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 850MG 50MG TABLET Resolved 2023-03-02 2023-10-06 185954
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Resolved 2023-03-02 2023-07-27 185964
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Resolved 2023-03-02 2023-07-27 185957
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 500MG 50MG TABLET Resolved 2023-10-20 2023-11-06 207683
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-QUETIAPINE 25MG TABLET Discontinued 2020-07-10 2020-07-10 119950
APO-QUININE 200MG CAPSULE Discontinued 2018-09-08 2021-05-10 60711
APO-QUININE 300MG CAPSULE Discontinued 2018-09-08 2021-05-10 60714
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71201
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71204
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2018-02-23 2019-09-12 40805
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2018-09-08 2018-10-05 60717
APO-RAMIPRIL 1.25MG CAPSULE Discontinued 2018-09-08 2019-03-29 60720
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2018-12-28 60726
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2019-02-13 60723
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2019-01-02 2019-01-09 70810
APO-RANITIDINE TABLET 300MG 300MG TABLET To be discontinued 2018-09-08 2018-09-08 60732
APO-RANITIDINE TABLET 300MG 300MG TABLET Discontinued 2018-09-08 2018-09-15 60729
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60735
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60738
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60741
APO-RILUZOLE 50MG TABLET To be discontinued 2025-12-02 2025-12-02 257819
APO-RILUZOLE 50MG TABLET To be discontinued 2018-09-08 2018-09-08 60744
APO-RISEDRONATE 35MG TABLET Discontinued 2018-09-08 2018-09-15 60747
APO-RISEDRONATE 35MG TABLET Discontinued 2018-10-19 2018-10-19 64965